Cargando…
Efficacy between low and high dose aspirin for the initial treatment of Kawasaki disease: Current evidence based on a meta-analysis
BACKGROUND: Kawasaki disease (KD) is now the leading cause of acquired heart disease in children in developed countries. Intravenous immunoglobulin (IVIG) and aspirin were considered as the standard initial treatment of KD for decades. However, the optimal dose of aspirin has remained controversial....
Autores principales: | Zheng, Xiaolan, Yue, Peng, Liu, Lei, Tang, Changqing, Ma, Fan, Zhang, Yi, Wang, Chuan, Duan, Hongyu, Zhou, Kaiyu, Hua, Yimin, Wu, Gang, Li, Yifei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6531010/ https://www.ncbi.nlm.nih.gov/pubmed/31117119 http://dx.doi.org/10.1371/journal.pone.0217274 |
Ejemplares similares
-
Is there an association between intravenous immunoglobulin resistance and coronary artery lesion in Kawasaki disease?—Current evidence based on a meta-analysis
por: Zheng, Xiaolan, et al.
Publicado: (2021) -
N-terminal pro-brain natriuretic peptide as a biomarker for predicting coronary artery lesion of Kawasaki disease
por: Zheng, Xiaolan, et al.
Publicado: (2020) -
Ventricular arrhythmia as an initial sign in acute Kawasaki disease: A case report
por: Hu, Fan, et al.
Publicado: (2018) -
Predictive value of coagulation profiles for both initial and repeated immunoglobulin resistance in Kawasaki disease: A prospective cohort study
por: Shao, Shuran, et al.
Publicado: (2021) -
Kawasaki Disease Complicated by Late-Onset Fatal Cerebral Infarction: A Case Report and Literature Review
por: Wang, Lin, et al.
Publicado: (2021)